Emerald Clinics

Emerald Clinics is an alternative healthcare provider specialising in medical cannabis. The company operates a handful of clinics spread around Australia and specialises in ongoing counselling and treatment for Australians taking cannabis medications. The provider also offers telehealth consultations. 

Emerald Clinics is best known for it’s ‘real-world evidence’ (RWE) data and clinical research. Emerald Clinics is heavily involved in medical cannabis research and is currently partnered with Zelira Therapeutics to conduct research on insomnia, chronic pain and autism using data from Emerald Clinics’s patients. 

Emerald Clinics board includes CEO Dr. Michael Winlo, Matthew Callahan and Sir Professor John Tooke.

Emerald Clinics was listed on the Australian Stock Exchange as EMD in February 2020. Emerald Clinics is also a part of the global alternative healthcare company Emyria and operates in the UK’s medical cannabis market.